A Machine-Based Learning Model for Recurrence Prediction and Timing After Endoscopic Eradication Therapy for Barrett’s Esophagus
Clinical Gastroenterology and Hepatology · 2026-11 · 24 (11) · 2956-2967
DOI: 10.1016/j.cgh.2026.03.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-11. Verfasst von Venkata Akshintala und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland. Hauptthemen laut MEDLINE: Barrett Esophagus, Machine Learning, Esophageal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Anschutz Medical Campus, University of Colorado.
Abstract (Originalsprache)
BACKGROUND & AIMS: Tools that can predict recurrence in patients with Barrett's esophagus (BE)-related neoplasia treated with endoscopic eradication therapies (EET) to guide surveillance decisions are needed. We aimed to develop and validate a machine learning (ML)-based prediction tool to predict the risk and timing of recurrence status post EET. METHODS: Three prospective United States databases of patients who underwent EET for BE-related neoplasia and achieved complete eradication of intestinal metaplasia (CE-IM; n = 1114) were utilized to develop and internally validate a ML-based prediction tool using the Random Forest model and imputation techniques. Predictors incorporated in this model included demographics, endoscopy and pathology results, and EET details. A Cox proportional hazards model was utilized to predict the time to recurrence. External validation was performed using the United States Radiofrequency Ablation database (n = 1397). RESULTS: BE recurrence occurred in 29.2% (n = 734) of patients and BE-related neoplasia recurrence in 10.6% (n = 265), with a mean time to recurrence of 21.3 months (mean follow-up, 37.7 months). The top predictors for recurrence included BE length, body mass index, age, sessions needed to achieve CE-IM, and baseline histology. The model was well-calibrated, and area under the receiver operating characteristic curve (AUC) was 0.92 (95% confidence interval [CI], 0.85-0.95) on internal validation and 0.91 (95% CI, 0.87-0.95) on external validation for BE recurrence. For BE-related neoplasia recurrence, the AUC was 0.90 (95% CI, 0.88-0.93). The model had moderate discriminative performance to predict timing of recurrence with a C-index of 0.701 at 1 year (AUC 0.71), 0.68 (AUC 0.69) at 3 years, and 0.66 (AUC 0.69) at 5 years. CONCLUSIONS: This United States-based externally validated tool accurately predicts BE and BE-related neoplasia recurrence and timing post EET. This practical tool may help provide a personalized approach to surveillance strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
- Department of Computer Science, Johns Hopkins University, Baltimore, Maryland.
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.
- Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Förderung
- Anschutz Medical Campus, University of Colorado
Zitieren
APA
Akshintala, V., Han, S., Yan, Y., Bisschops, R., Brennan, C., Cai, Y., Codipilly, D. C., Cotton, C., Early, D., Edmundowicz, S. A., Eluri, S., Gallegos, J., Goyal, R., Hammad, H. T., Haidry, R., Hollander, T., Husain, K., Iyer, P. G., Jojo, J., …, & Wani, S. (2026). A Machine-Based Learning Model for Recurrence Prediction and Timing After Endoscopic Eradication Therapy for Barrett’s Esophagus. Clinical Gastroenterology and Hepatology, 24(11), 2956-2967. https://doi.org/10.1016/j.cgh.2026.03.026
Vancouver
Akshintala V, Han S, Yan Y, Bisschops R, Brennan C, Cai Y, et al. A Machine-Based Learning Model for Recurrence Prediction and Timing After Endoscopic Eradication Therapy for Barrett’s Esophagus. Clinical Gastroenterology and Hepatology. 2026;24(11):2956-2967. doi:10.1016/j.cgh.2026.03.026
BibTeX
@article{Akshintala2026,
author = {Akshintala, Venkata and Han, Samuel and Yan, Yukun and Bisschops, Raf and Brennan, Case and Cai, Yanna and Codipilly, D Chamil and Cotton, Cary and Early, Dayna and Edmundowicz, Steven A and Eluri, Swathi and Gallegos, Jazmyne and Goyal, Rohit and Hammad, Hazem T and Haidry, Rehan and Hollander, Thomas and Husain, Khalid and Iyer, Prasad G and Jojo, Justeena and Kushnir, Vladimir and Komanduri, Srinadh and Leggett, Cadman and Lovat, Laurence and Muthusamy, V Raman and Rastogi, Amit and Seewald, Stefan and Shaheen, Nicholas J and Thaker, Adarsh and Vantanasiri, Kornpong and Jones, Craig and Wani, Sachin},
title = {A Machine-Based Learning Model for Recurrence Prediction and Timing After Endoscopic Eradication Therapy for Barrett’s Esophagus},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {11},
pages = {2956--2967},
doi = {10.1016/j.cgh.2026.03.026}
}
EUVIMED